Long-term use of recombinant human growth hormone in pediatric allograft recipients: a report of the NAPRTCS Transplant Registry

@article{Fine2004LongtermUO,
  title={Long-term use of recombinant human growth hormone in pediatric allograft recipients: a report of the NAPRTCS Transplant Registry},
  author={Richard N. Fine and Donald E Stablein},
  journal={Pediatric Nephrology},
  year={2004},
  volume={20},
  pages={404-408}
}
Data from the NAPRTCS database were analyzed for growth, allograft function, and targeted adverse events (AE) over a 5-year period in 513 recipients who received recombinant human growth hormone (rhGH) treatment and compared with the outcome of 2,263 concurrent controls who did not receive rhGH. Recipients less than 10 years of age grew better than older… CONTINUE READING